Middle East and Africa Medical Tourism Market Report

Middle East and Africa Medical Tourism Market Size

The Middle East and Africa medical tourism market was valued at USD 1.14 billion in 2025, is estimated to reach USD 1.24 billion in 2025, and is projected to reach USD 2.38 billion by 2034, growing at a CAGR of 8.5% from 2026 to 2034.

Medical tourism has become a strategic component of the regional healthcare and travel industries, reflecting both government investment and rising international demand. The market refers to the movement of patients from other countries seeking affordable, high quality, and specialised medical care in destinations such as the United Arab Emirates, Saudi Arabia, South Africa, Egypt, and Jordan. Patients travel for advanced procedures ranging from cosmetic and dental care to oncology, orthopaedics, cardiology, and fertility treatments, often paired with hospitality and wellness offerings that enhance the overall experience. Dubai registering over 674,000 medical tourists in 2022, as reported by the Dubai Health Authority. Saudi Arabia is investing heavily in transforming its healthcare infrastructure, with the Vision 2030 framework emphasising private sector participation and specialised medical cities. Africa too is gaining traction with South Africa known for its cost competitive cosmetic and surgical care, while Morocco and Egypt attract patients for dental and ophthalmology procedures.

MARKET DRIVERS

Surge in Medical Tourism Arrivals in Key Hubs Driven by Infrastructure Investment

The rapid increase in medical tourists arriving in established hubs due to major infrastructure investments and service enhancements is escalating the growth of the MEA medical tourism market. In 2023 Dubai welcomed over 691,000 international medical tourists, up from 674,000 in 2022, demonstrating solid year-on-year growth in cross-border patient travel. As per the Dubai Health Authority, the medical tourism sector generated over AED 1.03 billion in healthcare-related spending in 2023, compared with AED 992 million in 2022. These gains derive from investments in cutting edge hospitals, accreditation of healthcare facilities, integration of wellness tourism, and enhancement of patient-friendly amenities.

Cost-Competitiveness Compared to Western Countries and Rising Affordability

The cost competitiveness relative to Western and South Asian peers, which was combined with rising affordability is expected to enhance the growth of the MEA medical tourism market. Patients from within the GCC, Sub-Saharan Africa, and parts of Asia find that prices for procedures in hubs such as UAE, South Africa or Jordan can be significantly lower while quality remains high. Also, growth in middle class incomes in many African and South Asian countries is increasing the ability to pay for elective and nonemergency medical travel. Additionally increased medical insurance coverage and international insurance portability schemes are enabling more patients to consider overseas treatment. Enhanced accessibility via improved air connectivity and direct flights to medical hubs reduces travel friction.

MARKET RESTRAINTS

Severe Shortage of Qualified Healthcare Professionals

The lack of sufficient qualified medical personnel in many countries of the Middle East and Africa, which limits both capacity and quality of care is hindering the growth of the MEA medical tourism market. The existing workforce covers only about 43% of needs-based requirements as of 2022, meaning many systems are overstretched and unable to handle both local demand and incoming medical tourists. These shortages increase wait times, reduce procedural variety, make high end specialised treatments rarer, and often force medical tourism facilities to recruit from abroad or pay premiums for foreign talent.

Regulatory, Visa, and Travel Barriers with Infrastructure Gaps

The regulatory complexity, visa obstacles, and underdeveloped supporting infrastructure are additionally hampering the growth of the MEA medical tourism market. Travel visa restrictions or inconsistent regulations across countries can deter inbound medical tourists. For example certain Middle East nations have suspended visa issuance for tourists and workers from specific African and Asian countries, which may impact medical travellers too. Poor road, air transport, hotel‐hospital pipeline logistics, language and cultural differences further contribute to friction. These combined regulatory and infrastructure obstacles increase the perceived risks of travelling for medical care and reduce the attractiveness of destinations for medical tourists who often expect seamless cross border processes and international standard care.

MARKET OPPORTUNITIES

Development of accredited centres of excellence and high end specialised care hubs

The rapid public and private investment in world class hospitals and accredited clinics, which is setting up new opportunities for the growth of MEA medical tourism market. Dubai for example welcomed about 691,000 international medical tourists in 2023, whose spending on healthcare services exceeded AED 1.03 billion, illustrating how an invested hub can scale inbound demand quickly, as per the Dubai Health Authority. Governments and investors across the Gulf and North Africa are funding tertiary hospitals diagnostic centres and specialist units and are creating healthcare free zones and patient facilitation platforms that reduce friction for foreigners. These centres of excellence generate spillover benefits including higher skilled staffing, clinical trial activity, and domestic medical education which together raise perceived quality. For providers and investors this opportunity means focused capital allocation to accreditation pathways such as Joint Commission International and to patient experience services that bundle treatment with hospitality and travel.

Capture rising outbound spending and unmet regional demand driven by noncommunicable diseases and middle class growth.

There is a substantial pool of patients within Africa and neighbouring regions who currently travel abroad for care or who lack access to specialised services at home. Historically Africans spent over one billion dollars annually on medical services abroad according to World Bank related estimates often cited in regional analyses, which indicates a sizeable addressable market for on continent or near region alternatives. Combined with expanding middle classes, which is improving air connectivity and growth in cross border insurance portability and employer sponsored medical schemes this creates a growing cohort able and willing to pay for overseas care closer to home. Countries that can package competitively priced clinically credible services with transparent pricing and good aftercare stand to capture this spend that currently leaks to distant markets such as India or Europe.

MARKET CHALLENGES

Insurance Coverage Gaps and Lack of Standardization in Patient Financing

The lack of adequate insurance coverage or the lack of standardized policies across borders which creates financial unpredictability is likely to degrade the growth of the MEA medical tourism market. In many African countries insurance penetration remains low; for instance more than 60% of healthcare expenses in some Sub Saharan African states are still paid from personal funds. Lack of standardized processes for insurer approval of overseas treatments means that even when patients have insurance, approvals, documentation and payment delays reduce the appeal of overseas travel. Patient financing uncertainty undermines planning and trust, especially for more expensive or complex procedures.

Regulatory Complexity Visas Accreditation and Continuity of Care

The regulatory obstacles, visa restrictions, accreditation variance and difficulties with follow up care are limiting the growth of the MEA medical tourism market. Many medical tourism destinations in the Middle East and Africa have varying accreditation standards; some facilities are internationally accredited, others less so, which leads to confusion over quality for prospective patients. According to a scoping study on medical tourism challenges five out of seven studies identified poor infrastructure and a shortage of medical tourism facilitators as significant barriers. Differences in language, legal recourse in case of complications, and a lack of standardized patient facilitation services also deter patients. These regulatory and visa plus continuity issues raise risk, costs and reduce patient confidence in choosing medical tourism destinations in the region.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Treatment Type Insights

The cosmetic treatment segment was the largest and held 24.1% of the global medical tourism market share in 2024. Cosmetic procedures often have shorter recovery times, are elective, and are not heavily restricted by life-threatening regulatory oversight in many MEA jurisdictions. Patients seeking cosmetic enhancements are frequently willing to pay out of pocket, providing high margin potential for providers. In places like Turkey and UAE cosmetic clinics compete on technology, brand, service experience, and cost. Clinics in Dubai, Istanbul, Cairo and Cape Town are combining holiday or wellness travel with aesthetic procedures.

The fertility treatment segment is likely to grow with a prominent CAGR during the forecast period. Around one in six adults (≈17.5 percent) globally experience infertility at some point, which compels many to seek specialized fertility treatments abroad where costs are lower or wait times are shorter. In the MEA region countries such as Lebanon, UAE, Egypt, and South Africa are becoming increasingly known for fertility clinics offering IVF, ICSI, donor services, egg freezing and related reproductive services. Patients from nearby countries travel for these services. Fertility clinics are advancing with cutting edge reproductive technologies, embryo screening, genetic testing, cryopreservation, etc. Additionally, some governments are supporting medical tourism via regulatory reforms that make licensing, accreditation, and oversight more standardized for fertility care.

REGIONAL ANALYSIS

United Arab Emirates (UAE) Medical Tourism Market Insights

The United Arab Emirates segment was the top performer of the Middle East and Africa medical tourism market with a significant share in 2024. The UAE benefits from world class healthcare infrastructure, high number of internationally accredited hospitals, and government efforts to ease visa processes and provide concierge services. The presence of free zones dedicated to healthcare (e.g. Dubai Healthcare City), high quality specialist clinics, and a focus on treatments such as cosmetic surgery, dental, and orthopaedics make the UAE unusually well positioned. Strategic marketing, excellence in patient experience, and digital health tools also support its dominance and rising share in the MEA medical tourism market.

Saudi Arabia Emirates (UAE) Medical Tourism Market Insights

Saudi Arabia was positioned second in the MEA medical tourism market. There is increasing demand for specialised treatments such as cardiology, cancer, orthopaedics, fertility and organ transplant in Saudi hospitals. Government-backed investments are improving hospital accreditation, attracting international talent, and improving patient service experience. The Kingdom’s strategic location between Africa, Asia and the Middle East gives it logistical advantages. In addition, demand from expatriate communities and neighbouring countries seeking advanced procedures is rising.

South Africa Emirates (UAE) Medical Tourism Market Insights

South Africa is another of the key medical tourism nations in the MEA region. The country also benefits from relatively good infrastructure (air connectivity, hospitality) particularly in cities like Cape Town, Johannesburg, and Durban. Increasing numbers of patients from other African countries travel to South Africa for procedures they cannot access or afford locally. Additionally South Africa has seen growth in recovery tourism patients combining medical care with leisure stays. The private sector hospitals are investing in accreditations, improved patient experience, and international marketing to attract more medical tourists.

COMPETITIVE LANDSCAPE

The Middle East and Africa medical tourism market is characterised by intense competition between globally recognised hospitals, regional private healthcare groups, and specialist clinics targeting niche treatments. The market features destinations such as the United Arab Emirates, Saudi Arabia, Israel, South Africa, and Egypt which compete by offering internationally accredited facilities, competitive pricing, and comprehensive patient care packages. Cleveland Clinic Abu Dhabi and Burjeel Holdings are dominant players in the Gulf due to their advanced technology and concierge level services while South African private hospitals attract patients through lower cost elective surgeries and recovery tourism. Israel differentiates itself with advanced fertility and oncology treatments supported by a strong research and innovation ecosystem. Competition is not only among countries but also within regions as hospitals expand their digital presence, improve transparency of treatment costs, and promote bundled medical and leisure packages. Strategic partnerships with insurers, facilitators, and travel companies are increasingly important in capturing inbound demand.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global middle east and africa medical tourism market include

• Min-Sheng General Hospital
• Cleveland Clinic Abu Dhabi
• Burjeel Holdings VPS Healthcare
• Apollo Hospitals Enterprise Limited
• Samitivej Sukhumvit
• Fortis Healthcare Ltd.
• Prince Court Medical Center
• Bangkok Hospital Medical Center
• Asian Heart Institute
• KPJ Healthcare Berhad
• Raffles Medical Group
• Bumrungrad International Hospital

Top Players

Cleveland Clinic Abu Dhabi

Cleveland Clinic Abu Dhabi operates as a multispecialty tertiary care centre that attracts international patients to its advanced cardiac neuroscience oncology and transplant services. The facility builds on the Cleveland Clinic’s reputation for integrated multidisciplinary care and clinical governance to offer bundled patient journeys that include concierge logistics high end diagnostics and robust post discharge follow up. To strengthen its appeal to Asia Pacific patients the institution has scaled telemedicine consultations and second opinion services and participates in clinical collaborations and knowledge exchange with hospitals in Singapore and other regional hubs. These initiatives reduce travel uncertainty and shorten clinical decision timelines for prospective patients in Asia Pacific who seek timely access to complex tertiary procedures.

Burjeel Holdings VPS Healthcare

Burjeel Holdings under the VPS Healthcare umbrella runs a network of hospitals and specialty centres across the Gulf and has positioned itself as a patient centric medical tourism provider offering orthopaedics cardiology fertility and cosmetic care. The group has invested in international patient services clinical accreditations and premium hospitality oriented care packages to attract high value inbound clients.

Apollo Hospitals Group

Apollo Hospitals Group is a major Asian health system that both receives medical travellers from the Middle East and works with MEA partners to deliver cross border care. The group emphasises centres of excellence in oncology cardiac care and organ transplantation and has developed structured international patient programs including financing support telehealth pre assessment and coordinated travel logistics.

MARKET SEGMENTATION

This research report on the Middle East and Africa medical tourism market has been segmented and sub-segmented into the following categories.

By Treatment Type

• Cardiovascular Treatment
• Orthopedic Treatment
• Fertility Treatment
• Neurological Treatment
• Dental Treatment
• Cancer Treatment
• Cosmetic Treatment
• Others

By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA